Exousia Bio, Inc.

Exousia Bio, Inc. is a development-stage U.S. company focused on building an eLearning and gaming platform that teaches children financial literacy and resource management. Its core concept is the twoplus1® educational game, which is intended to combine subscription access with in-game monetization features such as virtual property trading commissions.

−93,4 %

1 370,5 %

−67,4 %

— Exousia Bio, Inc.
%
Educational gaming platform70% Interactive game-based learning products designed to teach children financial knowledge and resource management.
Subscription access20% Recurring access to the twoplus1® platform and its educational content.
Virtual property monetization10% In-game trading and transaction features intended to generate commissions.

The company appears to sell primarily to families and children through a consumer-facing digital learning product, with...

  • Children and young learnersprimary

    Buy or use the game for interactive lessons in finance, property, and resource management.

  • Parents and guardiansprimary

    Support purchases because the product combines entertainment with educational value.

  • Educational institutionsemerging

    Potential future buyers of the platform for classroom or enrichment use.

Exousia Bio is incorporated in Wyoming and operates as a U.S.-based startup, but the reports also note trademark...

  • •Incorporated in Wyoming, United States
  • •Primary operating base appears to be the U.S.
  • •twoplus1® trademark protected in the United Kingdom
  • •Plans to expand IP protection into other key regions
  • •No country-level revenue disclosure provided

The company’s strategy is to enter the eLearning and gaming markets with a niche product that teaches financial...

01
Launch and commercialize twoplus1®short-term

The company needs a marketable product before it can generate meaningful revenue.

02
Secure funding for operations and marketingshort-term

The company has limited cash and a going-concern risk, so external capital is required to continue development.

03
Protect and expand intellectual propertymedium-term

Trademark protection supports brand recognition and reduces imitation risk as the product expands.

The company is a development-stage business with minimal revenue, limited operations, and an auditor-issued...

critical

Going-concern and liquidity risk

The company has limited operations, minimal cash, and an auditor warning about its ability to continue.

Scope
May force delays, downsizing, or cessation of planned operations if capital is not raised.
Materiality
high
high

Financing risk

Operations are expected to be funded through additional equity or debt issuances.

Scope
Dilution or unfavorable financing terms could pressure shareholders.
Materiality
high
high

Product commercialization risk

Revenue depends on launching and monetizing a new educational game and subscription platform.

Scope
Delayed launch or weak adoption would limit revenue generation.
Materiality
high
medium

Cybersecurity and third-party service risk

The company plans to rely on cloud providers and consultants while handling customer and partner data.

Scope
Security incidents could disrupt operations or damage trust.
Materiality
medium
Going concern
Affects confidence in asset realization, liability settlement, and future operations
Management estimates
Can materially affect expenses, liabilities, and any future revenue recognition
Revenue recognition
Could affect reported revenue if services are delivered over time or transaction-based

EXOZYMES INC.

EXOZ · Biological Products, (No Diagnostic Substances)

Exceed World, Inc.

EXDW · Services-Educational Services

EXICURE, INC.

XCUR · Pharmaceutical Preparations

Duolingo, Inc.

DUOL · Services-Prepackaged Software

Superstar Platforms Inc.

SPST · Services-Business Services, NEC

Generation Bio Co.

Pharmaceutical Preparations

: 28/04/2026